14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.39 $5.20 Wednesday, 24th Apr 2024 AVXL stock ended at $3.41. This is 7.34% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 12.09% from a day low at $3.39 to a day high of $3.80.
90 days $3.39 $6.90
52 weeks $3.39 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Sep 24, 2020 $3.87 $3.99 $3.75 $3.87 454 558
Sep 23, 2020 $4.05 $4.07 $3.88 $3.90 578 137
Sep 22, 2020 $4.07 $4.12 $3.97 $4.06 610 895
Sep 21, 2020 $4.23 $4.28 $4.06 $4.09 561 376
Sep 18, 2020 $4.19 $4.52 $4.18 $4.25 1 405 806
Sep 17, 2020 $4.09 $4.27 $4.02 $4.19 493 437
Sep 16, 2020 $4.06 $4.14 $4.00 $4.06 369 499
Sep 15, 2020 $4.09 $4.18 $3.99 $4.02 449 825
Sep 14, 2020 $3.98 $4.12 $3.95 $4.06 604 897
Sep 11, 2020 $3.90 $4.06 $3.89 $3.91 431 349
Sep 10, 2020 $4.14 $4.16 $3.85 $3.88 454 835
Sep 09, 2020 $3.86 $4.11 $3.85 $4.08 588 517
Sep 08, 2020 $3.96 $4.00 $3.65 $3.80 708 101
Sep 04, 2020 $4.04 $4.04 $3.72 $3.81 738 938
Sep 03, 2020 $4.16 $4.18 $3.98 $3.99 374 629
Sep 02, 2020 $4.12 $4.19 $3.95 $4.19 526 050
Sep 01, 2020 $4.26 $4.28 $4.10 $4.11 254 381
Aug 31, 2020 $4.22 $4.27 $4.12 $4.24 372 589
Aug 28, 2020 $4.16 $4.26 $4.13 $4.18 398 380
Aug 27, 2020 $4.19 $4.24 $4.05 $4.20 406 968
Aug 26, 2020 $3.99 $4.19 $3.99 $4.16 441 616
Aug 25, 2020 $4.12 $4.17 $3.96 $3.98 534 872
Aug 24, 2020 $4.40 $4.40 $4.09 $4.13 739 574
Aug 21, 2020 $4.34 $4.40 $4.24 $4.39 480 733
Aug 20, 2020 $4.47 $4.47 $4.27 $4.37 369 394
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT